Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial
Hanauer, Stephen B., Sandborn, William J., Kornbluth, Asher, Katz, Seymour, Safdi, Michael, Woogen, Scott, Regalli, Gino, Yeh, Chyon, Smith-Hall, Nancy, Ajayi, FunmilayVolume:
100
Language:
english
Journal:
The American Journal of Gastroenterology
DOI:
10.1111/j.1572-0241.2005.00248.x
Date:
November, 2005
File:
PDF, 146 KB
english, 2005